34206-49-0 Usage
General Description
5-Bromo-2,3-dihydroxypyridine is a chemical compound that consists of a pyridine ring with two hydroxyl groups at the 2 and 3 positions, as well as a bromine atom at the 5 position. It is commonly used as a building block in the synthesis of pharmaceutical compounds and agrochemicals. 5-BROMO-2,3-DIHYDROXYPYRIDINE has potential biological activity and has been studied for its potential use in treating neurological disorders and as an antioxidant. 5-Bromo-2,3-dihydroxypyridine is also used in organic synthesis as a versatile intermediate in the production of various functional molecules. It is important to handle this chemical with care, as it may be toxic if ingested or absorbed through the skin, and appropriate safety measures should be taken when working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 34206-49-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,0 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 34206-49:
(7*3)+(6*4)+(5*2)+(4*0)+(3*6)+(2*4)+(1*9)=90
90 % 10 = 0
So 34206-49-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H4BrNO2/c6-3-1-4(8)5(9)7-2-3/h1-2,8H,(H,7,9)
34206-49-0Relevant articles and documents
Synthesis and biological activity of 10-aza-narciclasine
Vshyvenko, Sergey,W'Giorgis, Zemane,Weber, Audrey,Neverova, Natalia,Hedberg, Bradley,Hudlicky, Tomas
, p. 83 - 87 (2015)
The first active aza analogue of narciclasine was synthesized from a pentasubstituted derivative of nicotinic acid. The key features of the synthesis include a halogen dance of bromopyridine and an intramolecular Heck reaction with a conduramine derived chemoenzymatically from bromobenzene. 10-Aza-narciclasine was found to have reasonable activity against several cancer cell lines.
NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS
-
Page/Page column 62, (2010/02/07)
Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.